APO RESEARCH · REPORT
Pruritus Therapeutics
Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex.
Product & engineering
Understand the product.
Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex.
In this report, we study the drugs for pruritus.
Selected research
Industry Research
Pruritus Therapeutics Industry Research Report 2026
Market perspective
Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex.
In this report, we study the drugs for pruritus.
Market competition is intense. J&J, Abbott, Amgen and LEO Pharma, etc. are the leaders of the industry, with about 60% market shares.
Read the full market overview
North America is the largest consumption place, with a revenue market share nearly 43%. Following North America, Europe is the second largest consumption place with the revenue market share of 27%.
Report Scope
This report quantifies the global Pruritus Therapeutics market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pruritus Therapeutics.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pruritus Therapeutics Market by Company
J&J
Abbott
Amgen
LEO Pharma
Novartis
Bayer
Pfizer
UCB Pharma
GlaxoSmithKline
Galderma
Huapont
Pruritus Therapeutics Segment by Type
Antihistamines
Corticosteroids
Calcineurin Inhibitors
Others
Pruritus Therapeutics Segment by Application
External Use
Oral
Injection
Pruritus Therapeutics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pruritus Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pruritus Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pruritus Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pruritus Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Antihistamines
- Corticosteroids
- Calcineurin Inhibitors
- Others
Applications
- External Use
- Oral
- Injection
Companies covered
- J&J
- Abbott
- Amgen
- LEO Pharma
- Novartis
- Bayer
- Pfizer
- UCB Pharma
- GlaxoSmithKline
- Galderma
- Huapont
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pruritus Therapeutics by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Antihistamines
- 2.2.3 Corticosteroids
- 2.2.4 Calcineurin Inhibitors
- 2.2.5 Others
- 2.3 Pruritus Therapeutics by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 External Use
- 2.3.3 Oral
- 2.3.4 Injection
- 2.4 Assumptions and Limitations
3 Pruritus Therapeutics Breakdown Data by Type
- 3.1 Global Pruritus Therapeutics Historic Market Size by Type (2021-2026)
- 3.2 Global Pruritus Therapeutics Forecasted Market Size by Type (2027-2032)
4 Pruritus Therapeutics Breakdown Data by Application
- 4.1 Global Pruritus Therapeutics Historic Market Size by Application (2021-2026)
- 4.2 Global Pruritus Therapeutics Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pruritus Therapeutics Market Perspective (2021-2032)
- 5.2 Global Pruritus Therapeutics Growth Trends by Region
- 5.2.1 Global Pruritus Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pruritus Therapeutics Historic Market Size by Region (2021-2026)
- 5.2.3 Pruritus Therapeutics Forecasted Market Size by Region (2027-2032)
- 5.3 Pruritus Therapeutics Market Dynamics
- 5.3.1 Pruritus Therapeutics Industry Trends
- 5.3.2 Pruritus Therapeutics Market Drivers
- 5.3.3 Pruritus Therapeutics Market Challenges
- 5.3.4 Pruritus Therapeutics Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pruritus Therapeutics Players by Revenue
- 6.1.1 Global Top Pruritus Therapeutics Players by Revenue (2021-2026)
- 6.1.2 Global Pruritus Therapeutics Revenue Market Share by Players (2021-2026)
- 6.2 Global Pruritus Therapeutics Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pruritus Therapeutics Head Office and Area Served
- 6.4 Global Pruritus Therapeutics Players, Product Type & Application
- 6.5 Global Pruritus Therapeutics Manufacturers Established Date
- 6.6 Global Pruritus Therapeutics Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pruritus Therapeutics Market Size (2021-2032)
- 7.2 North America Pruritus Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pruritus Therapeutics Market Size by Country (2021-2026)
- 7.4 North America Pruritus Therapeutics Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pruritus Therapeutics Market Size (2021-2032)
- 8.2 Europe Pruritus Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pruritus Therapeutics Market Size by Country (2021-2026)
- 8.4 Europe Pruritus Therapeutics Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pruritus Therapeutics Market Size (2021-2032)
- 9.2 Asia-Pacific Pruritus Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pruritus Therapeutics Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pruritus Therapeutics Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pruritus Therapeutics Market Size (2021-2032)
- 10.2 South America Pruritus Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pruritus Therapeutics Market Size by Country (2021-2026)
- 10.4 South America Pruritus Therapeutics Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pruritus Therapeutics Market Size (2021-2032)
- 11.2 Middle East & Africa Pruritus Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pruritus Therapeutics Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pruritus Therapeutics Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 J&J
- 12.1.1 J&J Company Information
- 12.1.2 J&J Business Overview
- 12.1.3 J&J Revenue in Pruritus Therapeutics Business (2021-2026)
- 12.1.4 J&J Pruritus Therapeutics Product Portfolio
- 12.1.5 J&J Recent Developments
- 12.2 Abbott
- 12.2.1 Abbott Company Information
- 12.2.2 Abbott Business Overview
- 12.2.3 Abbott Revenue in Pruritus Therapeutics Business (2021-2026)
- 12.2.4 Abbott Pruritus Therapeutics Product Portfolio
- 12.2.5 Abbott Recent Developments
- 12.3 Amgen
- 12.3.1 Amgen Company Information
- 12.3.2 Amgen Business Overview
- 12.3.3 Amgen Revenue in Pruritus Therapeutics Business (2021-2026)
- 12.3.4 Amgen Pruritus Therapeutics Product Portfolio
- 12.3.5 Amgen Recent Developments
- 12.4 LEO Pharma
- 12.4.1 LEO Pharma Company Information
- 12.4.2 LEO Pharma Business Overview
- 12.4.3 LEO Pharma Revenue in Pruritus Therapeutics Business (2021-2026)
- 12.4.4 LEO Pharma Pruritus Therapeutics Product Portfolio
- 12.4.5 LEO Pharma Recent Developments
- 12.5 Novartis
- 12.5.1 Novartis Company Information
- 12.5.2 Novartis Business Overview
- 12.5.3 Novartis Revenue in Pruritus Therapeutics Business (2021-2026)
- 12.5.4 Novartis Pruritus Therapeutics Product Portfolio
- 12.5.5 Novartis Recent Developments
- 12.6 Bayer
- 12.6.1 Bayer Company Information
- 12.6.2 Bayer Business Overview
- 12.6.3 Bayer Revenue in Pruritus Therapeutics Business (2021-2026)
- 12.6.4 Bayer Pruritus Therapeutics Product Portfolio
- 12.6.5 Bayer Recent Developments
- 12.7 Pfizer
- 12.7.1 Pfizer Company Information
- 12.7.2 Pfizer Business Overview
- 12.7.3 Pfizer Revenue in Pruritus Therapeutics Business (2021-2026)
- 12.7.4 Pfizer Pruritus Therapeutics Product Portfolio
- 12.7.5 Pfizer Recent Developments
- 12.8 UCB Pharma
- 12.8.1 UCB Pharma Company Information
- 12.8.2 UCB Pharma Business Overview
- 12.8.3 UCB Pharma Revenue in Pruritus Therapeutics Business (2021-2026)
- 12.8.4 UCB Pharma Pruritus Therapeutics Product Portfolio
- 12.8.5 UCB Pharma Recent Developments
- 12.9 GlaxoSmithKline
- 12.9.1 GlaxoSmithKline Company Information
- 12.9.2 GlaxoSmithKline Business Overview
- 12.9.3 GlaxoSmithKline Revenue in Pruritus Therapeutics Business (2021-2026)
- 12.9.4 GlaxoSmithKline Pruritus Therapeutics Product Portfolio
- 12.9.5 GlaxoSmithKline Recent Developments
- 12.10 Galderma
- 12.10.1 Galderma Company Information
- 12.10.2 Galderma Business Overview
- 12.10.3 Galderma Revenue in Pruritus Therapeutics Business (2021-2026)
- 12.10.4 Galderma Pruritus Therapeutics Product Portfolio
- 12.10.5 Galderma Recent Developments
- 12.11 Huapont
- 12.11.1 Huapont Company Information
- 12.11.2 Huapont Business Overview
- 12.11.3 Huapont Revenue in Pruritus Therapeutics Business (2021-2026)
- 12.11.4 Huapont Pruritus Therapeutics Product Portfolio
- 12.11.5 Huapont Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst